Rheumatoid Arthritis News

Therapy discontinuance and 1-year response rates for Janus kinase and interleukin-6 inhibitors are similar to those of TNF inhibitors in patients with rheumatoid arthritis, according to data published in Annals of the Rheumatic Diseases.

The June 24 Supreme Court decision to overturn Roe vs. Wade continues to reverberate across all of health care, including rheumatology, dermatology and cancer treatment — and in this instance all three at once.

Female patients with rheumatoid arthritis are more likely to achieve remission when treated with exogenous sex hormones, particularly those who are perimenopausal and early postmenopausal, according to data published in Rheumatology.

Prediction models for rheumatoid arthritis outcomes, including infection and stroke, demonstrated strong performance and may be viable as a study tool for clinical use, according to data published in Seminars in Arthritis and Rheumatism.

The most frequent cause of death in patients with rheumatoid arthritis-associated interstitial lung disease and also those with idiopathic pulmonary fibrosis is acute exacerbation, researchers reported.

Tofacitinib shows no evidence of an increased risk for malignancies compared with TNF inhibitors when used to treat rheumatoid arthritis, according to data published in Arthritis & Rheumatology.

Patients with immune mediated diseases and treated with tumor necrosis factor-alpha inhibitors have a modest risk for new onset psoriasis, according to a study.

Federal law prohibits pharmacies from refusing to fill prescriptions that may end a pregnancy to patients who are able to become pregnant, according to a newly released HHS guidance.

Add-on low-dose prednisolone improves long-term disease activity and progression in senior patients with established rheumatoid arthritis, albeit with an increase in non-severe adverse events, according to data.

Consuming specific dietary components such as vitamin D or omega-3 is “unlikely to influence the progression” of rheumatic and musculoskeletal diseases, according to a report of systemic reviews published in RMD Open.